Lunai Bioworks Inc. (LNAI) — 10-K Filings
All 10-K filings from Lunai Bioworks Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Lunai Bioworks Pivots to AI Cancer Diagnostics After Key Acquisitions
— Sep 29, 2025 Risk: high
Lunai Bioworks Inc. (LNAI) is a pre-clinical-stage biotechnology company that shifted its primary focus to AI-driven molecular diagnostics and oncology followin -
Renovaro Inc. Files 2024 10-K
— Oct 10, 2024 Risk: medium
Renovaro Inc. filed its 10-K for the fiscal year ending June 30, 2024, reporting its financial performance and business operations. The company, formerly known
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX